Song D, Cismas S, Crudden C, Trocme E, et al. Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma. Oncogene 2023 Feb 9. doi: 10.1038/s41388-023-02607.
PMID: 36759575